Skip to Content

Quillivant XR Approval History

  • FDA approved: Yes (First approved September 27th, 2012)
  • Brand name: Quillivant XR
  • Generic name: methylphenidate
  • Dosage form: for Extended-Release Oral Suspension
  • Company: NextWave Pharmaceuticals, Inc.
  • Treatment for: ADHD

Quillivant XR (methylphenidate) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Development History and FDA Approval Process for Quillivant XR

Oct  1, 2012Approval NextWave Pharmaceuticals Receives FDA Approval of Quillivant XR for Once-Daily Treatment of ADHD

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.